Compare CALY & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CALY | HTFL |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | United States |
| Employees | 28000 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | N/A | N/A |
| Metric | CALY | HTFL |
|---|---|---|
| Price | $13.98 | $27.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $16.50 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 2.0M | 1.6M |
| Earning Date | 05-07-2026 | 05-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.23 | $27.66 |
| Revenue Next Year | N/A | $23.55 |
| P/E Ratio | $64.24 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.26 | $20.13 |
| 52 Week High | $16.65 | $41.22 |
| Indicator | CALY | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 50.44 | 58.59 |
| Support Level | $13.18 | $25.56 |
| Resistance Level | $13.96 | $28.98 |
| Average True Range (ATR) | 0.48 | 1.63 |
| MACD | 0.08 | 0.27 |
| Stochastic Oscillator | 44.83 | 66.72 |
Callaway Golf Co is a golf equipment, gear and apparel company with a portfolio of world-wide brands, including Callaway Golf, Odyssey, TravisMathew, and OGIO. Callaway designs, manufactures, and sells high-performance golf clubs, golf balls, apparel, bags, and other accessories-setting the standard for performance in the game of golf. The company has two operating and reportable business segments: Golf Equipment and Apparel, Gear and Other. Geographically, the company operates in United States, Europe, Asia, and Rest of World, of which it derives maximum revenue from United States.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.